Oppenheimer & Co’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $996K | Buy |
106,214
+87,506
| +468% | +$821K | 0.01% | 855 |
|
|
2025
Q1 | $133K | Buy |
18,708
+823
| +5% | +$5.85K | ﹤0.01% | 1500 |
|
|
2024
Q4 | $209K | Buy |
+17,885
| New | +$209K | ﹤0.01% | 1438 |
|
|
2023
Q4 | – | Sell |
-7,810
| Closed | -$247K | – | 1436 |
|
|
2023
Q3 | $247K | Sell |
7,810
-372
| -5% | -$11.8K | 0.01% | 1199 |
|
|
2023
Q2 | $334K | Buy |
+8,182
| New | +$334K | 0.01% | 1127 |
|
|
2021
Q4 | – | Sell |
-1,824
| Closed | -$245K | – | 1538 |
|
|
2021
Q3 | $245K | Sell |
1,824
-447
| -20% | -$60K | ﹤0.01% | 1306 |
|
|
2021
Q2 | $368K | Buy |
+2,271
| New | +$368K | 0.01% | 1153 |
|